HomeSHRX • CVE
add
Sharp Therapeutics Corp
Previous close
$2.10
Year range
$0.23 - $5.00
Market cap
62.89M CAD
Avg Volume
17.00
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.72M | 1,363.87% |
Net income | -2.39M | -626.94% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.72M | -1,413.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 956.60K | -72.55% |
Total assets | 1.95M | -57.14% |
Total liabilities | 2.13M | 8.09% |
Total equity | -176.60K | — |
Shares outstanding | 30.08M | — |
Price to book | -210.00 | — |
Return on assets | -172.61% | — |
Return on capital | -225.52% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.39M | -626.94% |
Cash from operations | -975.60K | 33.47% |
Cash from investing | — | — |
Cash from financing | -15.57K | -100.31% |
Net change in cash | -1.04M | -132.16% |
Free cash flow | -380.30K | — |
About
Founded
2021
Headquarters
Website
